Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus(VRE): a systematic review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus(VRE): a systematic review ; volume:14 ; number:1 ; day:31 ; month:3 ; year:2014 ; pages:1-13 ; date:12.2014
BMC infectious diseases ; 14, Heft 1 (31.3.2014), 1-13, 12.2014
- Urheber
-
Shenoy, Erica S.
- Beteiligte Personen und Organisationen
-
Paras, Molly L.
Noubary, Farzad
Walensky, Rochelle P.
Hooper, David C.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-177
- URN
-
urn:nbn:de:1111-2016030315267
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shenoy, Erica S.
- Paras, Molly L.
- Noubary, Farzad
- Walensky, Rochelle P.
- Hooper, David C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
P067: Economic burden of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant enterococci in hospitals
Spatiotemporal prediction of vancomycin-resistant Enterococcus colonisation
Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)
Vancomycin-resistant Staphylococcus aureus endangers Egyptian dairy herds
Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci
Concomitant Vancomycin-Resistant Enterococcus faecium and Clostridium difficile Colitis
Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis
Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017
Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan
P067: Economic burden of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant enterococci in hospitals
Spatiotemporal prediction of vancomycin-resistant Enterococcus colonisation
Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)
Vancomycin-resistant Staphylococcus aureus endangers Egyptian dairy herds
Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci
Concomitant Vancomycin-Resistant Enterococcus faecium and Clostridium difficile Colitis
Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis
Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017
Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan
P067: Economic burden of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant enterococci in hospitals
Spatiotemporal prediction of vancomycin-resistant Enterococcus colonisation
Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)
Vancomycin-resistant Staphylococcus aureus endangers Egyptian dairy herds
Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci
Concomitant Vancomycin-Resistant Enterococcus faecium and Clostridium difficile Colitis
Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis
Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017
Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
Economic burden of nosocomial infections caused by vancomycin-resistant enterococci